Roche Holding and its unit Genentech agreed to purchase development and marketing rights to antibodies against influenza viruses from the Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute. The institutes are entitled to license payments, milestone fees and royalties from the companies if research on the antibodies results in drugs and diagnostics.

Related Summaries